388 results on '"Thrombocytopenia -- Care and treatment"'
Search Results
2. Researchers from Xiyuan Hospital Describe Findings in Thrombocytopenia [Hemostatic Mechanism of Jianpi Yiqi Shexue Decoction ((Sic)(Sic)(Sic)(Sic)(Sic) (Sic)(Sic)) In Treatment of Immune Thrombocytopenia]
3. Keymed Biosciences reports safety and efficacy results of CM313 for primary immune thrombocytopenia published in NEJM
4. New Thrombocytopenia Findings from Trakya University Published (Management of Adult Primary Immune Thrombocytopenia: Delphi- Based Consensus Recommendations)
5. Study Data from First Affiliated Hospital of Soochow University Provide New Insights into Thrombocytopenia (Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a ...)
6. New Thrombocytopenia Study Findings Reported from Third People's Hospital (Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study)
7. Thrombocytopenia Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight
8. PHI PEDIATRIC DISEASE CLINIC invites tenders for Conditional Budget Drugs for 2024, Biological Therapy, Growth Hormone, Inhalation Therapy and Therapy for Chronic Immune Thrombocytopenia
9. Reports Outline Thrombocytopenia Findings from University of Miami Health System (Management of Chemotherapy-induced Thrombocytopenia: Guidance From the Isth Subcommittee On Hemostasis and Malignancy)
10. Recent Findings in Thrombocytopenia Described by Researchers from Anhui Medical University (Novel Local Therapy for Post-injection Haematoma In an Athlete Patient With Severe Fever With Thrombocytopenia Syndrome: a Case Report)
11. Reports from University of Minnesota Advance Knowledge in Thrombocytopenia (Quality Improvement Approaches To Heparin-induced Thrombocytopenia: a Scoping Review)
12. 'China NMPA accepts and grants priority review status to Hutchmed's NDA for sovleplenib to treat primary immune thrombocytopenia
13. Gyre Therapeutics Announces China's NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
14. Gyre Therapeutics Announces China's NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
15. Clover reports positive results from phase I trial of SCB-219M to treat cancer patients with chemotherapy-induced thrombocytopenia
16. Reports Summarize Thrombocytopenia Research from Peking University Institute of Hematology (Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, ...)
17. Researchers from Massachusetts General Hospital Describe Findings in Thrombocytopenia (Novel Therapeutics and Future Directions for Refractory Immune Thrombocytopenia)
18. Phase III clinical study of recombinant human thrombopoietin injection (TEPIAO) for treatment of chronic liver disease-related thrombocytopenia achieved the pre-set primary endpoint
19. Research Results from Albert Einstein College of Medicine Update Understanding of Thrombocytopenia (Splenomegaly and Response to Splenectomy in Immune Thrombocytopenia)
20. Research on Thrombocytopenia Detailed by Researchers at Fuwai Hospital (Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis)
21. Keymed Biosciences Announced Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM
22. Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
23. Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
24. New Clinical Trial Research Study Results from Singapore General Hospital Described (A Randomized Cross-over Study of Cryopreserved Platelets In Prophylactic Transfusions of Thrombocytopenic Patients)
25. Studies from Southwest Medical University Further Understanding of Colony Stimulating Factors (Targeting a Thrombopoietin-independent Strategy In the Discovery of a Novel Inducer of Megakaryocytopoiesis, Dmag, for the Treatment of ...)
26. Researchers' Work from Federal Research Center Focuses on Thrombocytopenia (Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia)
27. HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status
28. HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status
29. Study Findings on Thrombocytopenia Are Outlined in Reports from New York City (Phase 2 study evaluating selinexor monotherapy in patients with JAKi-naive myelofibrosis and moderate thrombocytopenia)
30. Research on Thrombocytopenia Described by Researchers at Shandong University [Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial]
31. Symptoms of Primary Immune Thrombocytopenia (ITP): what it is, causes and treatment of the disease
32. Hutchmed completes patient enrollment in ESLIM-01 phase III trial of sovleplenib to treat primary immune thrombocytopenia
33. Clover Announces Positive Phase ,aa Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
34. Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
35. Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
36. Researchers at Dong-A University College of Medicine Zero in on Thrombocytopenia (Drug-induced immune-mediated thrombocytopenia due to bevacizumab-FOLFOX therapy: a case report)
37. Medical University of Silesia Researcher Describes Recent Advances in Atrial Fibrillation (Anticoagulants versus Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Co-Morbid Thrombocytopenia)
38. Research Results from Fudan University Update Understanding of Thrombocytopenia (Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study)
39. Findings on Thrombocytopenia Reported by Investigators at University Hospital Cent Asturias (Linezolid Induced Thrombocytopenia In Critically Ill Patients: Risk Factors and Development of a Machine Learning-based Prediction Model)
40. Data from Nanjing Medical University Advance Knowledge in Thrombocytopenia (Imipenem Cilastatin Sodium-associated Thrombocytopenia In an Older Patient: a Case and Literature Review)
41. Researcher from University of Milan Reports on Findings in Thrombocytopenia (Clonal Hematopoiesis in Patients with Immune Thrombocytopenia: Preliminary Results of a Cross-Sectional Study)
42. Researcher at Harvard Medical School Details Research in Thrombocytopenia [VAYHIT3: An Open-Label, Single-Arm, Phase II Trial to Evaluate the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (ITP) Previously ...]
43. MedStar Georgetown University Hospital Researcher Reports Recent Findings in Thrombocytopenia (A Novel Online Decision Support Tool to Determine Practice Patterns and Concordance with Experts in the Treatment of Patients with Immune ...)
44. Chinese Academy of Medical Sciences Researcher Updates Current Data on Thrombocytopenia (CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial)
45. Findings from King's College Hospital NHS Foundation Trust Provide New Insights into Chronic Lymphocytic Leukemia (Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax ...)
46. Investigators from University of Maryland Target Thrombocytopenia (Cardiac Surgery In Acute Heparin-induced Thrombocytopenia Managed With Therapeutic Plasma Exchange and Intravenous Immunoglobulin)
47. New Thrombocytopenia Study Findings Reported from University of Texas MD Anderson Cancer Center (Review of Needle Electromyography Complications In Thrombocytopenic Cancer Patients)
48. Reports Summarize Thrombocytopenia Study Results from Institute of Hematology and Blood Diseases Hospital (Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim In Chinese Subjects With Immune Thrombocytopenia: a Phase I/ii Trial)
49. Rallybio Announces Proof-of-Concept Results and Development Updates for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
50. Reports from Peking University Provide New Insights into Thrombocytopenia (All-trans Retinoic Acid Plus High-dose Dexamethasone As First-line Treatment for Patients With Newly Diagnosed Immune Thrombocytopenia: a Multicentre, Open-label, ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.